Capecitabine: all 1,069 studies that test it

Page 4 of 11. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.

• Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast CancerCompletedNCT00534417Phase 2Results posted
• A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed GliomasCompletedNCT00532948Phase 1Results posted
• Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And LapatinibCompletedNCT00526669Phase 2Results posted
• Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From ChinaTerminatedNCT00508274Phase 3Results posted
• A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.CompletedNCT00502671Phase 4Results posted
• Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaCompletedNCT00496587Phase 2Results posted
• Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast CancerTerminatedNCT00496366Phase 2Results posted
• Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver CancerCompletedNCT00483405Phase 2Results posted
• Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast CancerCompletedNCT00477464Phase 2Results posted
• Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal CancerCompletedNCT00470184Phase 2Results posted
• Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical ModelCompletedNCT00468585Phase 1/2Results posted
• Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for RelapseTerminatedNCT00462865Phase 2Results posted
• Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid TumorCompletedNCT00454649Phase 1Results posted
• Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast CancerCompletedNCT00452673Phase 1Results posted
• A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.CompletedNCT00448136Phase 2Results posted
• Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric AdenocarcinomaCompletedNCT00447330Phase 2Results posted
• Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach CancerCompletedNCT00446290Phase 1Results posted
• Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal CancerCompletedNCT00444678Phase 2Results posted
• Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic CancerCompletedNCT00438256Phase 1/2Results posted
• Brain Metastases In ErbB2-Positive Breast CancerTerminatedNCT00437073Phase 2Results posted
• A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerCompletedNCT00435409Phase 3Results posted
• Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel CancerCompletedNCT00433550Phase 2Results posted
• Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal AdenocarcinomaTerminatedNCT00430027Not applicableResults posted
• Standard Versus Continuous Capecitabine in Advanced Breast CancerCompletedNCT00418028Phase 2/3Results posted
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00416494Phase 2Results posted
• Neo-adjuvant Chemotherapy in Locally Advanced Gastric CancerCompletedNCT00414271Phase 2Results posted
• A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic CarcinomaCompletedNCT00411762Phase 1/2Results posted
• Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00408564Phase 2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00408408Phase 3Results posted
• Study of XELOX With Cetuximab in Advanced Gastric CancerCompletedNCT00398398Phase 2Results posted
• Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine TumorsCompletedNCT00398320Phase 2Results posted
• Docetaxel and Oxaliplatin in Gastric CancerCompletedNCT00382720Phase 2Results posted
• Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast CancerCompletedNCT00365417Phase 2Results posted
• Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of VaterCompletedNCT00354887Phase 2Results posted
• Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity CancerTerminatedNCT00354601Phase 2Results posted
• Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach CancerTerminatedNCT00354224Phase 2Results posted
• Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast CancerTerminatedNCT00347438Phase 2Results posted
• Oxaliplatin and Capecitabine in Patients With Unresectable CholangiocarcinomaCompletedNCT00338988Phase 2Results posted
• Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer PatientsCompletedNCT00338039Phase 2Results posted
• S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By SurgeryTerminatedNCT00335959Phase 2Results posted
• Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal CancerCompletedNCT00321685Phase 2Results posted
• Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without BevacizumabTerminatedNCT00321100Phase 2Results posted
• Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas CancerCompletedNCT00320749Phase 1Results posted
• Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal CancerCompletedNCT00291486Phase 1Results posted
• Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic CancerCompletedNCT00290693Phase 2Results posted
• Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00290615Phase 2Results posted
• Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized TrialCompletedNCT00278863Phase 2Results posted
• Individualized Drug Treatment for Treating Patients With Pancreatic CancerTerminatedNCT00276744Phase 2Results posted
• Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00274768Phase 2Results posted
• Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck MalignanciesCompletedNCT00266279Phase 2Results posted
• Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or ChemoCompletedNCT00258310Phase 2Results posted
• Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal CancerTerminatedNCT00216086Phase 2Results posted
• Randomized Phase II Trial Induction Therapy for Early Stage Breast CancerCompletedNCT00209092Phase 2Results posted
• Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00203411Phase 2Results posted
• A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer PatientsCompletedNCT00201825Phase 2Results posted
• Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown PrimaryTerminatedNCT00201734Phase 1/2Results posted
• Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerTerminatedNCT00194792Phase 2Results posted
• Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryCompletedNCT00194779Phase 2Results posted
• Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary SiteCompletedNCT00193609Phase 2Results posted
• Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus CancerCompletedNCT00193128Phase 1/2Results posted
• Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction CancerCompletedNCT00183898Phase 2Results posted
• Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal CancerCompletedNCT00177307Phase 2Results posted
• A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus CancersTerminatedNCT00177255Phase 2Results posted
• Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal CancerCompletedNCT00159432Phase 2Results posted
• A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck CancerCompletedNCT00148122Phase 2Results posted
• Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer PatientsCompletedNCT00130533Phase 3Results posted
• EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast CancerCompletedNCT00129935Phase 3Results posted
• A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast CancerCompletedNCT00121836Phase 4Results posted
• Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney CancerCompletedNCT00121251Phase 1/2Results posted
• A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal CancerCompletedNCT00118755Phase 2Results posted
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal CancerCompletedNCT00114231Phase 2Results posted
• Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal CancerCompletedNCT00113230Phase 2Results posted
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon CancerCompletedNCT00112918Phase 3Results posted
• Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal CancerTerminatedNCT00107315Phase 2Results posted
• S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast CancerCompletedNCT00107276Phase 2Results posted
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic CancerCompletedNCT00100815Phase 2Results posted
• Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00093808Phase 2Results posted
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerCompletedNCT00093379Phase 2Results posted
• S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast CancerCompletedNCT00087152Phase 2Results posted
• Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction CarcinomaCompletedNCT00084617Phase 2Results posted
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT00082433Phase 3Results posted
• Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal CancerCompletedNCT00081289Phase 2Results posted
• Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT00080301Phase 3Results posted
• A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00077857Phase 2Results posted
• A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon CancerCompletedNCT00069121Phase 3Results posted
• A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal CancerCompletedNCT00069095Phase 3Results posted
• GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00068588Phase 2Results posted
• Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast CancerCompletedNCT00050167Phase 1Results posted
• S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00033540Phase 2Results posted
• Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast CancerCompletedNCT00024102Phase 3Results posted
• Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal CancerCompletedNCT00022698Phase 2Results posted
• A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon CancerCompletedNCT00009737Phase 3Results posted
• Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction AdenocarcinomaCompletedNCT07529613Phase 1/2
• Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood TestActive, not recruitingNCT07340567Phase 3
• Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast CancerTerminatedNCT07166367Phase 2
• Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast CancerCompletedNCT07143097Phase 2
• Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor PatientsTerminatedNCT07012330Phase 2
• A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerTerminatedNCT06568692Phase 2
• Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast CancerActive, not recruitingNCT06458413Phase 2
• Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal CancerActive, not recruitingNCT06417476Phase 2

← Capecitabine overview